Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Kruijtzer CM"'
Autor:
Helgason HH, Koolen SL, Werkhoven Ev, Malingre MM, Kruijtzer CM, Huitema AD, Schot ME, Smit WM, Beijnen JH, Schellens JH; Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.schellens@nki.nl.
Publikováno v:
Current clinical pharmacology [Curr Clin Pharmacol] 2014 May; Vol. 9 (2), pp. 139-47.
Autor:
Shu-Chang Ma1,2, Jia-Qi Zhang1, Tian-Hua Yan2, Ming-Xing Miao2, Ye-Min Cao1, Yong-Bing Cao1 ybcao@vip.sina.com, Li-Chao Zhang3 changhaiskin@163.com, Ling Li1 lingli_z163@163.com
Publikováno v:
Cancer Medicine. May2023, Vol. 12 Issue 10, p11073-11096. 24p.
Autor:
Helgason HH; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX Amsterdam, and Faculty of Pharmaceutical Sciences, Utrecht University, The Netherlands. h.helgason@nki.nl, Kruijtzer CM, Huitema AD, Marcus SG, ten Bokkel Huinink WW, Schot ME, Schornagel JH, Beijnen JH, Schellens JH
Publikováno v:
British journal of cancer [Br J Cancer] 2006 Oct 09; Vol. 95 (7), pp. 794-800. Date of Electronic Publication: 2006 Sep 12.
Autor:
Kruijtzer CM; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Boot H, Beijnen JH, Lochs HL, Parnis FX, Planting AS, Pelgrims JM, Williams R, Mathôt RA, Rosing H, Schot ME, Van Tinteren H, Schellens JH
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2003 Feb; Vol. 14 (2), pp. 197-204.
Autor:
Kruijtzer CM; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Schellens JH, Mezger J, Scheulen ME, Keilholz U, Beijnen JH, Rosing H, Mathôt RA, Marcus S, van Tinteren H, Baas P
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2002 Dec 01; Vol. 20 (23), pp. 4508-16.
Autor:
Kruijtzer CM; Department of Medical Oncology, the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Beijnen JH, Rosing H, ten Bokkel Huinink WW, Schot M, Jewell RC, Paul EM, Schellens JH
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2002 Jul 01; Vol. 20 (13), pp. 2943-50.
Autor:
Kruijtzer CM; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Beijnen JH, Schellens JH
Publikováno v:
The oncologist [Oncologist] 2002; Vol. 7 (6), pp. 516-30.
Autor:
Lee, Lucy1 (AUTHOR), Murase, Katsuyuki1 (AUTHOR), Ma, Jiyuan1 (AUTHOR), Thoolen, Martin1 (AUTHOR) mthoolen@ptcbio.com
Publikováno v:
Clinical Pharmacology in Drug Development. Mar2023, Vol. 12 Issue 3, p279-286. 8p.
Autor:
Schellens JH; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. jhm@nki.nl, Malingré MM, Kruijtzer CM, Bardelmeijer HA, van Tellingen O, Schinkel AH, Beijnen JH
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2000 Dec; Vol. 12 (2), pp. 103-10.
Autor:
Kruijtzer CM; The Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam. makru@nki.nl, Beijnen JH, Swart M, Schellens JH
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2000; Vol. 45 (5), pp. 428-31.